Related Experiment Video
Updated: Dec 19, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
COVID-19-Associated Myocarditis in an Adolescent
Brit Trogen1, Francisco J Gonzalez, Gail F Shust
1From the NYU School of Medicine, 550 First Avenue, New York, NY 10016.
A 17-year-old male experienced severe illness with septic shock and myocarditis due to SARS-CoV-2 infection. His cardiac function improved after treatment, showing the potential for recovery from COVID-19-related heart issues.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Cardiology
Background:
- Adolescent obesity as a potential risk factor for severe COVID-19 complications.
- Septic shock presentation in pediatric patients with novel coronavirus infection.
- Myocarditis as a serious cardiac manifestation of SARS-CoV-2.
Observation:
- A 17-year-old obese male presented with a 7-day history of fever, gastrointestinal symptoms, and neck pain, leading to fluid-responsive septic shock.
- Initial diagnostic workup confirmed SARS-CoV-2 infection and revealed elevated cardiac biomarkers: troponin I and brain natriuretic peptide.
- Cardiac imaging, including echocardiography and cardiac magnetic resonance imaging, diagnosed acute myocarditis.
Findings:
- The patient's septic shock was responsive to fluid resuscitation.
- Diagnostic confirmation of acute myocarditis in the context of SARS-CoV-2 infection.
- Follow-up echocardiography one week post-discharge indicated significant improvement in cardiac function, with only residual myocardial dysfunction.
Implications:
- Highlights the critical role of early recognition and management of pediatric septic shock and COVID-19-associated myocarditis.
- Suggests that prompt medical intervention can lead to favorable cardiac recovery in adolescents with severe SARS-CoV-2 infection.
- Emphasizes the need for comprehensive cardiac evaluation in pediatric patients presenting with severe systemic illness and confirmed SARS-CoV-2 infection.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
